Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adjuvant Osimertinib in EGFR-Mutated Non-Small-Cell Lung Cancer.

× No keyword cloud information.

9 in total

1. Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression.

Authors: Huanyuan Wang; Xiangwu Zhou; Zhaozhen Wang; Tianzhu Lu; Baoliang Li; Sicong Jiang
Journal: Evid Based Complement Alternat Med Date: 2022-05-25 Impact factor: 2.650

2. ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer.

Authors: Ana Ortega-Franco; Shereen Rafee
Journal: Oncol Ther Date: 2022-03-16

Review 3. MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Authors: Chao-Ju Chen; Yu-Peng Liu
Journal: Pharmaceuticals (Basel) Date: 2021-02-06

Review 4. Molecular biomarkers in early stage lung cancer.

Authors: María Rodríguez; Daniel Ajona; Luis M Seijo; Julián Sanz; Karmele Valencia; Jesús Corral; Miguel Mesa-Guzmán; Rubén Pío; Alfonso Calvo; María D Lozano; Javier J Zulueta; Luis M Montuenga
Journal: Transl Lung Cancer Res Date: 2021-02

5. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma.

Authors: Likui Fang; Wenfeng Yu; Guocan Yu; Fangming Zhong; Bo Ye
Journal: Med Sci Monit Date: 2022-01-16

6. The correlation of WDR76 expression with survival outcomes and immune infiltrates in lung adenocarcinoma.

Authors: Likui Fang; Guocan Yu; Wenfeng Yu; Gang Chen; Bo Ye
Journal: PeerJ Date: 2021-10-04 Impact factor: 2.984

7. Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States.

Authors: Terrance Peng; Heidi A Hamann; Elizabeth A David
Journal: JTO Clin Res Rep Date: 2022-02-25

8. Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling.

Authors: Ping Zhu; Zhengxin Jin; Guiyu Kang; Yanfei Jia; Duanrui Liu; Qian Zhang; Feiyang Guo; Ying Jia; Yang Jiao; Jingtan Li; Haiji Sun; Xiaoli Ma
Journal: Cell Commun Signal Date: 2022-08-15 Impact factor: 7.525

9. Comprehensive landscape of the ST3GAL family reveals the significance of ST3GAL6-AS1/ST3GAL6 axis on EGFR signaling in lung adenocarcinoma cell invasion.

Authors: Jiaxuan Li; Yiming Long; Jingya Sun; Jiajun Wu; Xiao He; Simei Wang; Xiongbiao Wang; Xiayi Miao; Ruimin Huang; Jun Yan
Journal: Front Cell Dev Biol Date: 2022-08-26

9 in total